CVS, Walgreens issued FDA warning letters for unapproved eye products

The U.S. Food and Drug Administration announced it has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. Eye products addressed in the eight warning letters are illegally marketed to treat conditions such as conjunctivitis, or “pink eye,” cataracts, glaucoma and others. Some of the FDA warning letters also cite the companies involved for quality issues related to product sterility. The agency issued warning letters to the following companies: Boiron Inc.; CVS Health (CVS); DR Vitamin Solutions; Natural Ophthalmics, Inc.; OcluMed LLC; Similasan AG/Similasan USA; TRP Company, Inc.; Walgreens Boots Alliance (WBA).